Logo-apb
Adv Pharm Bull. 2024;14(4): 759-793. doi: 10.34172/apb.42794

Review Article

Energy-Based Methods and Nanocarrier-Based Approaches for Melasma Treatment

Amiremad Kheirieh 1 ORCID, Amirhessam Kheirieh 2, Zahra Mahdavi 3, Ali Mohammad Halvani 3, Amir Mohammad Bagheri 4, Hooriyeh Nassirli 5, Shiva Golmohammadzadeh 1,6 * ORCID, Bizhan Malaekeh-Nikouei 1,6 * ORCID

Cited by CrossRef: 0


1- Toksoy M, Aşır F, Sabancılar İ. Development and characterization of tranexamic acid-loaded solid lipid nanoparticles for enhanced permeability: Release kinetics, in vitro cytotoxicity, and histological evaluation. Journal of Dispersion Science and Technology. 2025;:1 [Crossref]
2- Deb A, SB S, B S, HP S, AJ R. Advancements in drug delivery for hyperpigmentation: emerging therapies and future prospects. Cutaneous and Ocular Toxicology. 2025;:1 [Crossref]
3- Zhou M, Xiong R, Wang X, Li H, Wang L, Ling G, Zhang P. Microneedle Patches Coloaded with 4-MSK and C. Reinhardtii Alleviate Melanin Deposition Through Multipathway Synergy. ACS Appl Mater Interfaces. 2025; [Crossref]
4- Hofny E, Younis A, Badary D, Elnaggar M, Eleraky N, Abdel-Bary I, Badran A. Comparative study of different treatment modalities for melasma: introducing a novel nanotechnology-based tranexamic acid microemulsion. Arch Dermatol Res. 2025;317(1) [Crossref]